Augusta GA 卵巢癌临床试验
8项针对 卵巢癌的研究正在 Augusta及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- Augusta University, Augusta
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中3 期
- Georgia Cancer Center, Augusta
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- Georgia Cancer Center at Augusta University, Augusta
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
招募中3 期
- Augusta University - Georgia Cancer Center ( Site 0066), Augusta
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Augusta University Medical Center, Augusta
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- Augusta University Georgia Cancer Center, Augusta
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
招募中1/2 期
- Georgia Cancer Center, Augusta
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
招募中1/2 期
- Georgia Cancer Center at Augusta University, Augusta
其他城市的 卵巢癌试验
- Houston, TX89 项研究
- New York City, NY69 项研究
- Boston, MA61 项研究
- Los Angeles, CA50 项研究
- Nashville, TN49 项研究
- Arlington, VA46 项研究
- Philadelphia, PA44 项研究
- Columbus, OH39 项研究
- St. Louis, MO38 项研究
- Chicago, IL36 项研究
- San Antonio, TX31 项研究
- Cleveland, OH30 项研究
Augusta的其他研究
- 急性髓系白血病10 项研究
- 癌症（所有类型）7 项研究
- 子宫内膜癌7 项研究
- 镰状细胞病5 项研究
- 乳腺癌5 项研究
- 非霍奇金淋巴瘤4 项研究
- 弥漫性大B细胞淋巴瘤4 项研究
- 慢性髓系白血病4 项研究
- 血液癌症4 项研究
- 宫颈癌4 项研究
- 重症肌无力4 项研究
- 伯基特淋巴瘤4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。